
CARE Ratings Ltd. Share Price Target from 2025 to 2050: Future Outlook
CARE Ratings Ltd. (now part of the CareEdge Group) is India’s second-largest credit rating agency, providing corporate and structured finance credit ratings, ESG assessments, analytics, and advisory services. With recent initiatives in sovereign ratings and expansion into non-rating businesses, the company is evolving into a diversified financial intelligence firm. In this post, we explore CARE’s Share Price Target & Forecast 2025 to 2050, focusing on its core operations, investment appeal, and long-term strategic drivers.
CARE Ratings Ltd. Overview: Growth, Products, & Market Presence
Key Information | Details |
---|---|
Founded | 1993 (as Credit Analysis & Research Ltd.; IPO in December 2012) |
Headquarters | Mumbai, Maharashtra, India |
Sector | Credit Rating Agency, Analytics, ESG Rating & Advisory Services |
Key Services | Credit ratings (corporate, securitisation, bank debt), ESG ratings, analytics, consulting |
Stock Listings | NSE: CARERATINGS, BSE: 534804 |
Market Presence | Strong presence in India across corporate and structured finance; global reach through subsidiaries in Mauritius, Nepal, South Africa and CareEdge Global IFSC |
On this page, you will find detailed insights into CARE Ratings Ltd.’s stock, including real-time prices, technical analysis, and long-term forecasts:
✅ Real-Time Stock Price: Updated every minute with the latest market data.
✅ Technical Indicators: Tailored by time frame for accurate trading insights.
✅ Financial Reports: Published quarterly to reflect the company’s performance.
✅ Stock Charts: Refreshed in real time for visual market analysis.
📊 Note: CARE Ratings Ltd.’s stock forecast prices in the tables are automatically updated based on live asset price changes.
CARE Ratings Ltd. Financial Overview & Key Metrics
CARE Rating’s performance is driven by recurring credit rating fees, growth in non‑ratings analytics services, and expansion into ESG and sovereign rating segments. Its margins benefit from high-margin subscription-based business, and operational agility allows for substantial earnings leverage from scaled volume. Utility of consistent quality and regulatory credibility forms the backbone of its financial resilience.
Below is a detailed breakdown of its key financial figures, including revenue, net profit, earnings per share (EPS), and other crucial metrics. These insights enable investors to assess the company’s financial health and long-term growth potential.
Use the landscape mode for best viewing on mobile devices.
Investment Potential & Associated Risks
Why Consider Investing in CARE Ratings Ltd.?
Oligopolistic Presence in the Indian Credit Rating Space
As one of only a few major players, CARE benefits from structural pricing power and regulatory licensing, creating entry barriers and predictability in the core ratings business.
Diversifying into High‑Value Services like ESG and Sovereign Ratings
Launching ESG ratings, analytics with AI platforms, and sovereign credit ranking (covering 39 countries) positions the company into higher-margin advisory and global ratings markets.
Strong Growth in Rating Volume and Non-Rating Revenue
Recent quarters show ~19% growth in ratings revenue and ~37% growth in non-ratings streams like analytics and consulting services.
High Operating Margins with Recurring Revenue Model
EBITDA margins consistently above 45% reflect a low-capital, fee-based model where scale drives high returns and improving margins.
Global Footprint through CareEdge Global IFSC and Africa/Nepal subsidiaries
Expansion into global ratings via the IFSC subsidiary and presence in Africa and Nepal opens doors for sovereign and international credit assessments
Risks to Consider
- Reputational and Regulatory Vulnerabilities
Credit rating agencies face scrutiny—past controversies around ratings accuracy (e.g. IL&FS) demonstrate that rating errors can impact credibility and regulatory standing. - Limited Pricing Flexibility Against Pricing Regulation
Fees are regulated and companies must retain quality over speed; aggressive pricing competition or regulatory change may limit margin expansion. - Dependence on Corporate Borrowing and Capital Market Activity
Rating volumes correlate strongly with bond issuances and securitisation; a downturn in financing activity could reduce revenue growth. - Client Concentration and Slow Adoption of New Services
Transition into analytics, ESG, and advisory services requires adoption by large clients; slow traction may limit speed of growth in new lines. - Currency and Global Operations Risks
Currency volatility and regulatory compliance in overseas subsidiaries (e.g., Africa, IFSC) may expose revenue to geopolitical risks and operational complexity.
CARE Ratings Share Price Target: Tomorrow & Weekly Outlook
CARE Ratings stock price forecasts for tomorrow and the upcoming week are based on recent market trends, historical price movements, and key technical indicators. These projections provide valuable insights into potential price changes, enabling traders and investors to make informed decisions.
However, various factors can influence stock prices, including market sentiment, news updates, and global events; therefore, it’s always wise to stay updated and flexible with your strategies.
📊 Below, you will find the expected stock price targets for the coming days:
Date | Min. Price | Max. Price | Stock Price |
---|---|---|---|
21-Aug | 1556.57 | 1631.32 | 1592.99 |
22-Aug | 1524.16 | 1600.69 | 1562.63 |
25-Aug | 1521.38 | 1598.28 | 1560.16 |
26-Aug | 1523.02 | 1601.09 | 1563.33 |
27-Aug | 1541.07 | 1614.29 | 1578.90 |
28-Aug | 1510.25 | 1586.42 | 1546.37 |
29-Aug | 1478.86 | 1552.61 | 1516.01 |
01-Sep | 1474.77 | 1550.91 | 1513.54 |
02-Sep | 1478.52 | 1554.01 | 1516.71 |
Technical Analysis of CARE Ratings Ltd. Using Key Indicators
For CARE Ratings Ltd., you can leverage indicator-based technical analysis to identify optimal market entry and exit points. Adjust the time frame according to your trading strategy for more accurate insights.
How to Interpret Technical Analysis Signals:
✅ Sell” or “Strong Sell | Indicates bearish (negative) market sentiment, suggesting a potential decline. |
✅ Buy” or “Strong Buy | Indicates bullish (positive) market sentiment, signaling a potential uptrend. |
Time Frame Considerations:
- Short-Term Analysis (Intraday/Short Swing Trading): Use time frames ranging from 15 minutes to 2 hours.
- Medium to Long-Term Analysis: If you plan to hold for more than a week, use daily to weekly time frames.
Below, you will find technical indicator-based buy and sell signals based on different time frames to assist in your investment decisions.
Future Growth Drivers for CARE Ratings Ltd.
Expansion into New Rating Segments: The company is actively moving into niche segments like ESG ratings, SME ratings, and infrastructure project evaluations to diversify its offerings.
Rising Debt Market Participation: As India’s corporate bond market expands, CARE stands to benefit from the increased demand for credit ratings for debt instruments.
Digital Innovation in Ratings: The company is enhancing its digital tools and platforms to improve client servicing and reduce turnaround time for issuing ratings.
Global Collaborations & Outreach: Strategic alliances with international agencies can help CARE expand its methodology and reputation on a global scale.
Increased Government & PSU Focus: Continued issuance of debt by public sector enterprises and government-backed entities ensures long-term demand for ratings in India.
What Will Drive CARE Ratings’ Share Price Over the Coming Decades?
- Continued Growth in Corporate Bond Markets
India’s push toward deeper debt capital markets will fuel long-term demand for credit ratings across all sectors. - Diversification into Non-Traditional Ratings
Focus on segments like ESG and risk analytics allows CARE to tap into emerging trends in sustainability and compliance. - Stable Operating Model with Low Capex
An asset-light model helps sustain high profitability and makes the business resilient to economic shocks. - Enhanced Financial Transparency in India
Regulatory emphasis on transparency and disclosure supports long-term demand for professional rating services. - Global Recognition & Methodology Strength
Adoption of global best practices and collaborations can position CARE for cross-border mandates and expanded influence.
CARE Ratings Share Price Target & Forecast (2025-2050)
This long-term stock price forecast for CARE Ratings Ltd. is based on historical market trends, the company’s growth prospects, and industry analysis. While forecasting stock prices for the long term involves uncertainty, these forecasts help investors gain insight into potential future price movements.
📊 The following table presents the CARE Ratings share price target & forecast from 2025 to 2050, based on current market trends and available data.
Year | Min. Price | Max. Price |
---|---|---|
2025 | ₹ 1,643.91 | ₹ 1,808.38 |
2026 | ₹ 1,799.58 | ₹ 2,143.60 |
2027 | ₹ 2,136.80 | ₹ 2,476.99 |
2028 | ₹ 2,474.41 | ₹ 2,810.39 |
2029 | ₹ 2,810.91 | ₹ 3,154.93 |
2030 | ₹ 3,146.83 | ₹ 3,326.45 |
2031 | ₹ 3,443.62 | ₹ 3,840.88 |
2032 | ₹ 3,764.75 | ₹ 4,194.71 |
2033 | ₹ 4,085.01 | ₹ 4,547.57 |
2034 | ₹ 4,405.26 | ₹ 4,900.43 |
2035 | ₹ 4,725.52 | ₹ 5,203.26 |
2040 | ₹ 6,395.17 | ₹ 6,952.67 |
2050 | ₹ 9,633.21 | ₹ 10,449.59 |
The CARE Ratings Ltd. share price targets provided here are for informational purposes only. Both short-term and long-term stock price predictions are based on historical data and market trends, but actual prices may vary due to market fluctuations and external factors. This forecast assumes positive market conditions and does not account for unforeseen risks, economic uncertainties, or company-specific challenges. Investors should conduct their research before making any financial decisions.
Live Stock Chart & Price Trends – CARE Ratings Ltd.
Track CARE Ratings Ltd.’s stock performance in real time with our interactive chart below. This live tool provides up-to-the-minute price movements, trading volume, and market trends, helping investors and market watchers stay fully informed. Easily switch between intraday, daily, weekly, or monthly views, and apply a variety of technical indicators to support deeper analysis. Whether you’re actively trading or simply monitoring the market, this chart offers the insights you need to make smart, timely decisions.
🔗 Also Read: Divi’s Laboratories Share Price Target: Future Outlook
Divi’s Laboratories Ltd. is a globally recognized Indian pharmaceutical company known for manufacturing active pharmaceutical ingredients (APIs), intermediates, and custom synthesis of drug compounds. Read more
Expert Opinions & Market Sentiment
Brokerage & Analyst Ratings
- ICICI Securities: “Positive – CARE’s asset-light model and rising demand for ratings in the SME and ESG space make it a solid long-term play.”
- Kotak Institutional Equities: “Accumulate – With predictable earnings and scope for margin expansion, CARE fits well in a defensive portfolio.”
- Sharekhan: “Hold – Competitive intensity is high, but CARE remains well-positioned with a trusted brand and regulatory edge.”
Investor Sentiment & Market Trends
Institutional Interest: The company has seen stable participation from mutual funds and insurance companies, reflecting confidence in its fundamentals.
Retail Participation: Individual investors are increasingly viewing CARE as a reliable, low-risk, long-term wealth compounder.
Market Outlook: Overall sentiment remains moderately bullish, with investors valuing its consistent dividend payouts and resilient business model.
❓FAQs
What does CARE Ratings Ltd. do?
CARE Ratings is a credit rating agency that evaluates the financial strength and creditworthiness of companies, debt instruments, and projects.
Is CARE Ratings Ltd. a good long-term investment?
Yes, due to its steady revenue model, minimal capital intensity, and growing market demand, CARE is often considered a sound long-term pick.
How does CARE generate revenue?
CARE primarily earns through service fees charged for rating assignments, periodic renewals, and advisory services.
What makes CARE different from competitors like CRISIL or ICRA?
While the core services are similar, CARE’s strength lies in its deep domestic experience and faster turnaround in mid-market and SME ratings.
Price Prediction Methodology
Our predictions combine expert analysis, technical indicators, and algorithmic models to provide an informed outlook.
📊 Want to know more? Click here to read our full methodology.